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LETTER TOTHE EDITOR 
 
Reporting the Rates of Depression in Polycystic Ovary 
Syndrome (PCOS) 
 
Dear Dr Goldstein, 
 
Morotti et al. ( JSM, August 23, 2013) assessed depression in lean 
women with polycystic ovary syndrome (PCOS). They concluded 
that BMI accounted for some of the depression in PCOS and 
noted that this finding was in accord with the meta-analysis of 
anxiety and depression in PCOS by Barry et al. [1]. They also 
noted that this finding contrasts with the findings of Barnard 
et al. [2] and offered the explanation that “the Zung scale [3] used 
by Barnard et al. may have partly overestimated the incidence of 
depression in PCOS patients” (Morotti et al., p. 7 [4]).We believe 
that if there was an overestimate, it is more likely because of two 
features of the Barnard et al. article—self-report of PCOS diagnosis 
and not reporting the clinical significance of findings in the 
abstract—rather than a problem with the Zung scale [3]. 
A meta-analysis by Dokras et al. [5] reported prevalence rates 
of depression in PCOS ranging from 14% to 67%, thus the 
Barnard et al. rate of 67% is relatively high though not unreasonably 
so. However, we should note that Dokras et al. excluded the 
Barnard et al. study from their meta-analysis because the Barnard 
et al. study—being an internet survey-relied on self-reported diagnosis 
of PCOS. Thus, if the Barnard et al. rate of 67% is an 
overestimate of the true rate of depression in PCOS, this may 
reflect the influence of bias because of diagnosis of PCOS by 
self-report rather than a problem with the Zung scale. 
Furthermore, although the Barnard et al. [2] abstract states 
that 67% of the women with PCOS in their sample were 
depressed, the Results section shows that this rate was based on 
the cutoff for “minimal to mild depression” (a Zung score of 
50–59). Identifying depression in the abstract by using the lowest 
possible cutoff may leave someone who does not read the whole 
article with an impression which overestimates the degree of 
depression being reported, if not the rate of depression. In later 
parts of the article, it can be seen that the rate was much lower 
when higher cutoffs were applied. For example, between 10% 
and 18% of the PCOS group were in the “extreme depression” 
category (a Zung score of over 70). Thus, it seems that the particular 
cutoff used, rather than the Zung scale itself, may have 
caused the apparent overestimate of the degree of depression in 
PCOS. 
 
We recommend that a clear sense of the clinical significance of 
the findings of any given study should be reported in the abstract 
of an article, because this will minimize potential for ambiguity 
regarding rates and severity of clinical findings. Thus, although 
the Barnard et al. [2] article was clear in later sections of their 
article that the 67% rate was of minimal to mild depression, it 
would have been helpful to specify the clinical meaning of the 
findings in the abstract because many busy readers may not have 
time to read the full text of the article, nor perhaps have ready 
access to the full text of the article. 
 
In conclusion, it is unlikely that the Zung scale was to blame 
for any overestimate of depression in the Barnard et al. 2007 [2] 
article. However, the issues raised by Morotti et al. [4] are very 
useful in drawing our attention to a subtle but important point 
regarding what might be considered best practice in the reporting 
of statistics: the clinical significance of results should be highlighted 
clearly in the abstract. 
 
Yours sincerely, 
 John A. Barry, PhD,* Andrzej R. Kuczmierczyk, PhD,† and 
Paul J. Hardiman, MD, FRCOG* 
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